Immunotech Biopharm Ltd

06978

Company Profile

  • Business description

    Immunotech Biopharm Ltd is a cellular immunotherapy biopharmaceutical company in China. The company is focused on the research, development, and commercialization of T-cell immunotherapy. Its product EAL is a multi-target cellular immunotherapy product for the treatment of various types of cancer. Its product pipeline features classes of cellular immunotherapy products, including both non-genetically modified and genetically modified products, as well as both multi-target and single-target products. Its other products include the CAR-T cell series and the TCR-T cell series.

  • Contact

    No.1 Kangding Street
    8th Floor, Block 1, Guosheng Technology Park
    Beijing Economic-technological Development Area
    Beijing100176
    CHN

    T: +86 8610884002

    https://www.eaal.net

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    183

Stocks News & Analysis

stocks

Tesla: Reported China divestiture plan could clear path for SpaceX merger

Media report says Tesla is exploring divestiture plans to ease regulatory approval of a Tesla-SpaceX merger.
stocks

This onetime AI market darling is now surprisingly undervalued

This AI leader qualifies as a GARP stock today.
stocks

Undervalued ASX miner hits production homerun

Record volumes, lower costs and reduced debt underpin a stronger earnings outlook for ASX miner.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,137.0070.20-0.76%
CAC 408,509.6424.000.28%
DAX 4025,629.2417.210.07%
Dow JONES (US)52,485.03276.970.53%
FTSE 10010,868.0529.22-0.27%
HKSE25,884.4325.550.10%
NASDAQ25,373.85251.681.00%
Nikkei 22564,362.022,494.594.03%
NZX 50 Index13,699.2863.50-0.46%
S&P 5007,489.7252.090.70%
S&P/ASX 2008,976.8073.10-0.81%
SSE Composite Index3,832.2627.570.72%

Market Movers